Andrew Callos
Corporate Officer/Principal en CYTOKINETICS, INCORPORATED .
Fortuna: 4 M $ al 30/04/2024
Perfil
Mr. Andrew Callos is a Chief Commercial Officer & Executive VP at Cytokinetics, Inc. Mr. Callos was previously employed as a Vice President-US Cardiology & Metabolic Marketing by Pfizer Inc. and an Assistant Vice President-Marketing by Wyeth Pharmaceuticals, Inc. He received his undergraduate degree from Drexel University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 14/03/2024 | 63 887 ( 0.06% ) | 4 M $ | 30/04/2024 |
Cargos activos de Andrew Callos
| Empresas | Cargo | Inicio |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | 01/03/2021 |
Antiguos cargos conocidos de Andrew Callos.
| Empresas | Cargo | Fin |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | - |
Wyeth Pharmaceuticals, Inc.
 Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Ventas & Marketing | - |
Formación de Andrew Callos.
| Drexel University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| CYTOKINETICS, INCORPORATED | Health Technology |
| PFIZER, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Health Technology |
- Bolsa de valores
- Insiders
- Andrew Callos